Pediatric head injury Getty Images 1270596650

ABSTRACT & COMMENTARY

Is Autologous Bone Marrow Cell Therapy a Potential Treatment for Traumatic Brain Injury?

August 1, 2024

This study proposes that autologous bone marrow mononuclear intravenous infusion for severe traumatic brain injury in children appears safe and potentially may be efficacious.

Issue Date: August 1, 2024

Table of Contents

Dr. Barone (author) reports that he is a consultant for DTC Comfort, Quiet Mind Pillows, and Jazz Pharmaceuticals. Dr. Rubin (author) reports that he is an author for Merck. Dr. Perumal (author) reports that she is a consultant for EMD Serono and Genentech. All of the relevant financial relationships listed for these individuals have been mitigated. None of the remaining authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements